The pharmacology of 4H-3-methylcarboxyamide-1,3-benzoxazine-2-one (F.I. 6654), a compound acting on the central nervous system.
D000758:Anesthesia; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001463:Barbiturates / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D003864:Depression, Chemical; D004357:Drug Synergism; D000431:Ethanol / Q000494:pharmacology; D004987:Ethers; D005334:Fever / Q000139:chemically induced; D000882:Haplorhini; D007035:Hypothermia / Q000517:prevention & control; D007099:Imipramine / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009638:Norepinephrine / Q000494:pharmacology; D010078:Oxazines / Q000494:pharmacology*; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors / Q000633:toxicity; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D013268:Stimulation, Chemical; D013331:Strychnine / Q000037:antagonists & inhibitors / Q000633:toxicity; D014203:Tremorine / Q000037:antagonists & inhibitors / Q000494:pharmacology
D001463:Barbiturates; D004987:Ethers; D010078:Oxazines; D000431:Ethanol; D001285:Atropine; D012110:Reserpine; D013331:Strychnine; D007099:Imipramine; D014203:Tremorine; D010433:Pentylenetetrazole; D009638:Norepinephrine